Assetmark, Inc Ark Genomic Revolution ETF (De Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 03, 2022	SELL	$27.2 - $48.94 $1,550 - $2,789	-57 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$38.15 - $63.26 $2,174 - $3,605	57 New	57 $3,000
Q4 2021 Feb 14, 2022	SELL	$58.39 - $78.64 $782,250 - $1.05 Million	-13,397 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$73.87 - $92.86 $399,932 - $502,744	-5,414 Reduced 28.78%	13,397 $1 Million
Q2 2021 Aug 16, 2021	BUY	$73.64 - $93.1 $267,681 - $338,418	3,635 Added 23.95%	18,811 $1.74 Million
Q1 2021 May 14, 2021	BUY	$81.74 - $112.47 $132,173 - $181,863	1,617 Added 11.93%	15,176 $1.35 Million
Q4 2020 Feb 10, 2021	BUY	$63.39 - $105.53 $859,505 - $1.43 Million	13,559 New	13,559 $1.27 Million

Others Institutions Holding ARKG

# of Institutions

286

Shares Held

24.5M

Call Options Held

3.02M

Put Options Held

2.65M

Jpmorgan Chase & CO New York, NY

2.96M
Shares

$75.6 Million
0.01% of portfolio
Bank Of America Corp Charlotte, NC

2.9M
Shares

$74.3 Million
0.01% of portfolio
Main Management ETF Advisors, LLC San Francisco, CA

2.43M
Shares

$62.2 Million
2.95% of portfolio
Goldman Sachs Group Inc New York, NY

1.81M
Shares

$46.4 Million
0.01% of portfolio
Citigroup Inc

1.68M
Shares

$43 Million
0.03% of portfolio

About ARK GENOMIC REVOLUTION ETF (DE

Ticker ARKG
Sector ETFs
Industry ETFs

More about ARKG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.